Robert Kleinman 2024

Fentanyl, carfentanil and other fentanyl analogues in Canada’s illicit opioid supply: A cross-sectional study

Robert Kleinman

Despite the increase in fentanyl-involved overdose deaths in Canada, there have been no national-level studies evaluating the…

High-Dose Buprenorphine Initiation: A Scoping Review

Stanley Wong, Nicholas Fabiano, Declan Webber, Robert Kleinman

High-dose buprenorphine initiation has not been associated with reported cases of overdose or respiratory depression. However, the current literature about high-dose buprenorphine is limited by…

Rethinking Substance Use as Social History: Charting a Way Forward

Nikki Bozinoff, Robert Kleinman, Matthew Sloan, Mary Clare Kennedy, Seonaid Nolan, Peter Selby, Csilla Kalocsai, Evan Wood

Physicians have traditionally asked about substance use within the Social History section of the consultation note. Drawing on social science theory and using the authors’ own experiences as generalists and addiction scholars, we consider the possible unintended harms associated with this approach. The inclusion of the substance use history…

Characteristics, Treatment Patterns and Retention with Extended-Release Subcutaneous Buprenorphine for Opioid Use Disorder: A Population-Based Cohort Study in Ontario, Canada.

Anita Iacono, Tianru Wang, Mina Tadrous, Tonya Campbell, Gillian Kolla, Pamela Leece, Beth Sproule, Robert Kleinman…

Uptake and retention for opioid agonist treatment (OAT) remains low. Novel extended-release formulations may improve OAT accessibility by reducing the frequency of healthcare visits. Our aim was to examine uptake, characteristics, treatment patterns and retention of individuals…